| Valuation studies? Our collective two cents H Kjellberg, A Mallard, DL Arjaliès, P Aspers, S Beljean, A Bidet, A Corsin, ... | 224 | 2013 |
| The Q (u) ALYfying hand: Health economics and medicine in the shaping of Swedish markets for subsidized pharmaceuticals E Sjögren, CF Helgesson The Sociological Review 55 (2_suppl), 215-240, 2007 | 98 | 2007 |
| Valuation studies and the critique of valuation L Doganova, M Giraudeau, CF Helgesson, H Kjellberg, F Lee, A Mallard, ... Valuation Studies 2 (2), 87-96, 2014 | 90 | 2014 |
| Valuation and Calculation at the Margins A Mennicken, E Sjögren Valuation Studies 3 (1), 1-7, 2015 | 60 | 2015 |
| ‘Accounting Talk’ Through Metaphorical Representations: Change Agents and Organisational Change in Home-Based Elderly Care M Carlsson-Wall, K Kraus, M Lund, E Sjögren European Accounting Review 25 (2), 215-243, 2016 | 43 | 2016 |
| Reasonable drugs: Making decisions with ambiguous knowledge E Sjögren Economic Research Institute, Stockholm School of Economics (EFI)., 2006 | 41 | 2006 |
| No finish line: How formalization of academic assessment can undermine clarity and increase secrecy KS Helgesson, E Sjögren Gender, Work and Organization 26 (4), 558-581, 2019 | 28 | 2019 |
| Glocal Pharma E Johnson, E Sjögren, C Åsberg Taylor & Francis, 2016 | 26 | 2016 |
| Accounting and professional work in established NPM settings E Sjögren, K Fernler Accounting, Auditing & Accountability Journal 32 (3), 897-922, 2019 | 17 | 2019 |
| Five years! Have we not had enough of valuation studies by now? L Doganova, M Giraudeau, H Kjellberg, CF Helgesson, F Lee, A Mallard, ... Valuation Studies 5 (2), 83-91, 2018 | 17 | 2018 |
| More Knowledge, Better Government? Consequences of Knowledge‐Based Decision Making in Swedish Pharmaceutical Benefits ÅC Vifell, E Sjögren Governance 24 (1), 85-110, 2011 | 17 | 2011 |
| Identifying need through expressions of demand: Deciding on public financial intervention within the fields of healthcare and development aid A Krohwinkel-Karlsson, E Sjögren Routledge 10 (2), 197-220, 2008 | 15 | 2008 |
| Decision usefulness explored: An investigation of capital market actors' use of financial reports A Hjelstrom, T Hjelstrom, E Sjogren Stockholm, Svenskt Naringsliv, 2014 | 14* | 2014 |
| Deciding subsidy for pharmaceuticals based on ambiguous evidence E Sjögren Journal of health organization and management 22 (4), 368-383, 2008 | 14 | 2008 |
| The legal mind of the internal market: A governmentality perspective on the judicialization of monitoring practices ÅC Vifell, E Sjögren JCMS: Journal of Common Market Studies 52 (3), 461-478, 2014 | 13 | 2014 |
| Artful objects: Graham Harman on art and the business of speculative realism I Nilson, E Wikberg Sternberg Press; Stockholm School of Economics, 2020 | 7 | 2020 |
| Role attribution in public sector accountability processes: Dynamic and situation-specific accountor and constituent roles E Hagbjer, K Kraus, J Lind, E Sjögren Qualitative Research in Accounting & Management 14 (4), 367-389, 2017 | 7 | 2017 |
| Defining ‘markets’ for pharmaceuticals in Sweden: Public policy and commercialization E Sjogren Minerva 45 (2), 161-173, 2007 | 6 | 2007 |
| Verktyg för att realisera samverkan: En vetenskaplig undersökning av TioHundraprojektet E Sjögren, P Åhblom På väg mot en värdefull styrning: Ersättningssystem för en sammanhållen vård …, 2012 | 5* | 2012 |
| Democratic Priority Setting? Organizing Multiple Stakeholders to Make Decisions in the Healthcare Sector E Sjögren, K Fernler Organizing Democracy, 2010 | 5 | 2010 |
